News
Britain partners with Oxford firm to assess coronavirus vaccine...
Britain has signed supply deals for six different coronavirus vaccine candidates, including those being made by AstraZeneca and Pfizer and BioNTech, seen as among the...
News
ATMPS’s blockchain platform the world’s first solution for personalized...
ATMPS's Hataali blockchain platform has been successfully tested with University Hospitals Birmingham NHS Foundation Trust’s system interface.
Data interoperability was shown to be possible, rendering the...
News
Xerox Highlights COVID-19, Diversity and Climate Change Efforts in...
Xerox Holdings Corporation has published its 2020 Global Corporate Social Responsibility Report detailing data, accomplishments and goals relating to its work regarding the environment, society...
News
Moderna CEO Says COVID-19 Vaccine Could Get Emergency Approval...
As the top three COVID-19 vaccine projects get closer to the finish line, everybody is paying attention to when they might be available. Moderna recently...
News
Brazil COVID-19 vaccine trial continues despite volunteer death
Clinical trials of the Covid-19 vaccine being developed by Oxford University and AstraZeneca PLC will continue in Brazil despite the death a volunteer, Brazilian health...
Clinical Trials
GSK presents positive clinical data on maternal and older...
GSK announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in Phase...
News
AstraZeneca’s Trixeo Aerosphere recommended for approval in the EU...
AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.